County
Pend Oreille County Emergency Medical Services
The current listed document is more than 24 months old and may be outdated.
Drugs and doses50
A–C Acetaminophen, Activated Charcoal, Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate9
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 650–1000 mg | PO/PR | not captured | standing | page 206 |
| Fever | peds | 15 mg/kg | PO/PR | not captured | standing | page 206 |
| Mild to moderate pain | adult | 650–1000 mg | PO/PR | not captured | standing | page 206 |
| Mild to moderate pain | peds | 15 mg/kg | PO/PR | not captured | standing | page 206 |
Activated Charcoal
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25 g | PO | not captured | standing | page 268 |
| Other | adult | 25 g | PO | not captured | standing | page 268 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV/IO | not captured | standing | page 145 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 145 |
| Wide-complex tachycardia | adult | 6 mg | IV/IO | not captured | standing | page 148 |
| Wide-complex tachycardia | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 148 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 216 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 216 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 216 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 216 |
| Crush injury | adult | 5 mg | NEB | not captured | standing | page 237 |
| Crush injury | peds | 5 mg | NEB | not captured | standing | page 237 |
| Hyperkalemia | adult | 5 mg | NEB | not captured | standing | page 168 |
| Hyperkalemia | peds | 5 mg | NEB | not captured | standing | page 168 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 149 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 149 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 147 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 147 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 147 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 147 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 137 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5 mg | IV/IO | not captured | standing | page 143 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 143 |
| Nerve agent exposure | adult | 2 mg | IM | not captured | standing | page 172 |
| Nerve agent exposure | peds | 0.02–0.05 mg/kg | IM | not captured | standing | page 172 |
| Organophosphate poisoning | adult | 2 mg | IM | not captured | standing | page 172 |
| Organophosphate poisoning | peds | 0.02–0.05 mg/kg | IM | not captured | standing | page 172 |
| RSI induction | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 85 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 500–1000 mg | IV/IO | not captured | standing | page 275 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 10 mg/kg | IV/IO | not captured | standing | page 275 |
| Burns | adult | 500–1000 mg | IV/IO | not captured | standing | page 275 |
| Burns | peds | 10 mg/kg | IV/IO | not captured | standing | page 275 |
| Crush injury | adult | 500–1000 mg | IV/IO | not captured | standing | page 275 |
| Crush injury | peds | 10 mg/kg | IV/IO | not captured | standing | page 275 |
| Hyperkalemia | adult | 500–1000 mg | IV/IO | not captured | standing | page 275 |
| Hyperkalemia | peds | 10 mg/kg | IV/IO | not captured | standing | page 275 |
| Other | adult | 500–1000 mg | IV/IO | not captured | standing | page 275 |
| Other | peds | 10 mg/kg | IV/IO | not captured | standing | page 275 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2000 mg | IV/IO | not captured | standing | page 276 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 2–8 mL | IV/IO | not captured | standing | page 276 |
| Crush injury | adult | 2000 mg | IV/IO | not captured | standing | page 276 |
| Crush injury | peds | 2–8 mL | IV/IO | not captured | standing | page 276 |
| Hyperkalemia | adult | 2000 mg | IV/IO | not captured | standing | page 276 |
| Hyperkalemia | peds | 2–8 mL | IV/IO | not captured | standing | page 276 |
| Other | adult | 2000 mg | IV/IO | not captured | standing | page 276 |
| Other | peds | 2–8 mL | IV/IO | not captured | standing | page 276 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Fentanyl, Furosemide10
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 4–10 mg | IV/IO/IM/PO | not captured | standing | page 277 |
| Allergic reaction | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 277 |
| Anaphylaxis | adult | 4–10 mg | IV/IO/IM/PO | not captured | standing | page 277 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 277 |
| Asthma / bronchospasm | adult | 4–10 mg | IV/IO/IM/PO | not captured | standing | page 277 |
| Asthma / bronchospasm | adult | 4–10 mg | IV/IO/IM/PO | not captured | standing | page 277 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 277 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 277 |
| Croup | adult | 4–10 mg | IV/IO/IM/PO | not captured | standing | page 277 |
| Croup | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 277 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 12.5–25 g | IV/IO | not captured | standing | page 278 |
| Hyperkalemia | peds | 1 g/kg | IV/IO | not captured | standing | page 278 |
| Hypoglycemia | adult | 12.5–25 g | IV/IO | not captured | standing | page 278 |
| Hypoglycemia | peds | 1 g/kg | IV/IO | not captured | standing | page 278 |
| Other | adult | 12.5–25 g | IV/IO | not captured | standing | page 278 |
| Other | peds | 1 g/kg | IV/IO | not captured | standing | page 278 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5–10 mg | IV/IO | not captured | standing | page 279 |
| Hypothermia | adult | 5–10 mg | IV/IO | not captured | standing | page 279 |
| Nerve agent exposure | adult | 5–10 mg | IV/IO | not captured | standing | page 279 |
| Organophosphate poisoning | adult | 5–10 mg | IV/IO | not captured | standing | page 279 |
| Other | adult | 5–10 mg | IV/IO | not captured | standing | page 279 |
| Seizure | adult | 5–10 mg | IV/IO | not captured | standing | page 279 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 280 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 12.5–50 mg | IV/IO/IM | not captured | standing | page 281 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 281 |
| Anaphylaxis | adult | 12.5–50 mg | IV/IO/IM | not captured | standing | page 281 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 281 |
| Dystonic reaction | adult | 12.5–50 mg | IV/IO/IM | not captured | standing | page 281 |
| Dystonic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 281 |
| Nausea / vomiting | adult | 12.5–50 mg | IV/IO/IM | not captured | standing | page 281 |
| Nausea / vomiting | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 281 |
| Other | adult | 12.5–50 mg | IV/IO/IM | not captured | standing | page 281 |
| Other | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 281 |
| Procedural sedation | adult | 12.5–50 mg | IV/IO/IM | not captured | standing | page 281 |
| Procedural sedation | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 281 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–20 mcg/kg | IV/IO | not captured | standing | page 143 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 282 |
| Hypotension / shock | peds | 1–20 mcg/kg | IV/IO | not captured | standing | page 282 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.01 mg/kg | IV/IO | not captured | standing | page 159 |
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 155 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 155 |
| Anaphylaxis | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 159 |
| Asthma / bronchospasm | adult | 0.01 mg/kg | SQ | not captured | standing | page 285 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | page 144 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 144 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 141 |
| Cardiac arrest | adult | 2 mg | ET | not captured | standing | page 104 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 141 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1–0.3 mg/kg | IV/IO | not captured | standing | page 286 |
| RSI induction | adult | 0.3 mg/kg | IV/IO | not captured | standing | page 85 |
| RSI induction | peds | 0.1–0.3 mg/kg | IV/IO | not captured | standing | page 85 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1–2 mcg/kg | IV/IO/IM | not captured | standing | page 287 |
| Mild to moderate pain | adult | 25–50 mcg | IN | not captured | standing | page 114 |
| Mild to moderate pain | peds | 0.5–1 mcg/kg | IV/IO/IM | not captured | standing | page 287 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 0.5–1 mg/kg | IV/IO | not captured | standing | page 288 |
| CHF / pulmonary edema | peds | 2 mg/kg | IV/IO | not captured | standing | page 288 |
G–L Glucagon, Heparin, Hydromorphone, Hydroxocobalamin, Ipratropium, Ketamine, Ketorolac, Labetalol, Lidocaine, Lorazepam10
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 3–5 mg | IV/IO | not captured | standing | page 289 |
| Beta-blocker / calcium-channel-blocker overdose | adult | 3–5 mg | IV/IO | not captured | standing | page 289 |
| Hypoglycemia | adult | 1 mg | IM/SQ | not captured | standing | page 289 |
| Hypoglycemia | peds | 0.05 mg/kg | IM/SQ | not captured | standing | page 289 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 60 unit/kg | IV | not captured | standing | page 290 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 0.5 mg | IV/IO | not captured | standing | page 291 |
| Severe pain | adult | 1–2 mg | IM | not captured | standing | page 291 |
| Severe pain | peds | 0.015 mg/kg | IV/IO | not captured | standing | page 291 |
| Severe pain | peds | 0.015 mg/kg | IM | not captured | standing | page 291 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 5 g | IV | not captured | standing | page 170 |
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 292 |
| Cyanide poisoning | adult | 5 g | IV | not captured | standing | page 170 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 500 mcg | NEB | not captured | standing | page 215 |
| Asthma / bronchospasm | peds | 0.25 mg | NEB | not captured | standing | page 215 |
| Organophosphate poisoning | adult | 500 mcg | NEB | not captured | standing | page 294 |
| Organophosphate poisoning | peds | 0.25 mg | NEB | not captured | standing | page 294 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5–10 mg/kg | IM | not captured | standing | page 163 |
| RSI induction | adult | 1–2 mg/kg | IV | not captured | standing | page 85 |
| RSI induction | adult | 4–5 mg/kg | IM | not captured | standing | page 85 |
| RSI induction | peds | 1.5 mg/kg | IV | not captured | standing | page 85 |
| RSI induction | peds | 4–5 mg/kg | IM | not captured | standing | page 85 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 15–30 mg | IV/IO | not captured | standing | page 296 |
| Severe pain | adult | 30–60 mg | IM | not captured | standing | page 296 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5–10 mg | IV | not captured | standing | page 297 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | page 85 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | page 85 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.5–2 mg | IV/IO/IM/IN | not captured | standing | page 325 |
| Agitation | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 325 |
| Post-intubation sedation | adult | 1–2 mg | IV/IO | not captured | standing | page 85 |
| Seizure | adult | 1–2 mg | IV/IO/IM/IN | not captured | standing | page 299 |
| Seizure | peds | 0.05–0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 299 |
M–O Magnesium Sulfate, Methylprednisolone, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Octreotide, Ondansetron, Oxymetazoline, Oxytocin12
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 300 |
| Other | adult | 2 g | IV/IO | not captured | standing | page 300 |
| Other | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 300 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | page 300 |
| VF / pulseless VT | peds | 25–50 mg/kg | IV/IO | not captured | standing | page 300 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 125 mg | IV/IO | not captured | standing | page 301 |
| Allergic reaction | peds | 2 mg/kg | IV/IO | not captured | standing | page 301 |
| Anaphylaxis | adult | 125 mg | IV/IO | not captured | standing | page 159 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO | not captured | standing | page 159 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO | not captured | standing | page 301 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO | not captured | standing | page 301 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 2.5–5 mg | IV/IO | not captured | standing | page 302 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–10 mg | IV/IO/IM/IN | not captured | standing | page 304 |
| Agitation | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 304 |
| Post-intubation sedation | adult | 2.5–10 mg | IV/IO/IM | not captured | standing | page 85 |
| Post-intubation sedation | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 85 |
| RSI induction | adult | 2.5–10 mg | IV/IO | not captured | standing | page 145 |
| RSI induction | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 145 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–6 mg | IV/IO | not captured | standing | page 138 |
| CHF / pulmonary edema | adult | 2–6 mg | IV/IO | not captured | standing | page 305 |
| Severe pain | adult | 2–6 mg | IV/IO | not captured | standing | page 305 |
| Severe pain | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 305 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4 mg | IV/IO/IM/IN | not captured | standing | page 306 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 306 |
| Other | adult | 0.4 mg | IV/IO/IM/IN | not captured | standing | page 160 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 160 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 136 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 152 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 8–12 mcg | IV/IO | not captured | standing | page 170 |
| Hypotension / shock | adult | 8–12 mcg | IV/IO | not captured | standing | page 170 |
| Hypotension / shock | peds | 0.05–0.1 mcg/kg | IV/IO | not captured | standing | page 170 |
| Hypotension / shock | peds | 0.05–0.1 mcg/kg | IV/IO | not captured | standing | page 170 |
Octreotide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 25–50 mcg | IV | not captured | standing | page 311 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | PO/SL | not captured | standing | page 154 |
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 154 |
| Nausea / vomiting | adult | 4 mg | PO/SL | not captured | standing | page 154 |
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 154 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 154 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 154 |
| Nausea / vomiting | peds | 4 mg | PO/SL | not captured | standing | page 154 |
| Nausea / vomiting | peds | 4 mg | PO/SL | not captured | standing | page 154 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–3 spray | IN | not captured | standing | page 155 |
| RSI induction | adult | 2–3 spray | IN | not captured | standing | page 155 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 179 |
P–R Pralidoxime, Promethazine, Rocuronium3
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 600–1800 mg | IV/IM | not captured | standing | page 314 |
| Nerve agent exposure | peds | 25–50 mg/kg | IV/IM | not captured | standing | page 314 |
Promethazine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 6.25–12.5 mg | IV/IM | not captured | standing | page 316 |
| Nausea / vomiting | adult | 6.25–12.5 mg | IV/IM | not captured | standing | page 316 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.6–1.2 mg/kg | IV | not captured | standing | page 317 |
| Other | peds | 0.6 mg/kg | IV | not captured | standing | page 317 |
| RSI induction | adult | 0.6–1.2 mg/kg | IV | not captured | standing | page 317 |
| RSI induction | peds | 0.6 mg/kg | IV | not captured | standing | page 317 |
S–Z Sodium Bicarbonate, Succinylcholine, Tenecteplase, Thiamine, Tranexamic Acid, Vecuronium6
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | page 318 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | page 318 |
| Crush injury | adult | 1 mEq/kg | IV/IO | not captured | standing | page 318 |
| Crush injury | peds | 1 mEq/kg | IV/IO | not captured | standing | page 318 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 318 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 318 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | page 318 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 318 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI paralysis | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 319 |
| RSI paralysis | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 319 |
Tenecteplase
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| STEMI | adult | 30–50 mg | IV | not captured | standing | page 320 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IM | not captured | standing | page 160 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 322 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV | not captured | standing | page 322 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 323 |
| Other | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 323 |
Cite this
Pend Oreille County Emergency Medical Services, United States EMS Protocol Census. 205 dose entries, effective 2021-11-01.
https://protoquiz.com/census/agencies/pend-oreille-county-emergency-medical-services/
The census is free and not for sale. Only public agencies are named.